Page 3 - Ligand Corporation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CStone anuncia que sugemalimab ha alcanzado su criterio de valoración principal en el CPCNP

CStone anuncia que sugemalimab ha alcanzado su criterio de valoración principal en el CPCNP
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesJason yangFrank jiangAdministration of drugsLigand corporationCstone plansNational administrationStadium nsclcStadium and nsclcUnited states suzhouIndependent centralGreat chinaChina hasPfizer inAbout eqrxYou want

CStone Announces the First-in-Class Registrational Clinical Trial of Sugemalimab Met its Primary Endpoint in Stage III NSCLC and Plans to Submit a New Drug Application

CStone Announces the First-in-Class Registrational Clinical Trial of Sugemalimab Met its Primary Endpoint in Stage III NSCLC and Plans to Submit a New Drug Application
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Jason yangFrank jiangCstone pharmaceuticalsPrnewswire cstone pharmaceuticalsDrug administrationData monitoring committeeU ligand corporationInternational agency for research on cancerNational medical products administration of chinaNational medical products administrationNew drug applicationBlinded independent central reviewGuangdong provincial peopleLeading principal investigatorChief medical officerGreater china